Incorrect Authorization Affecting nodejs-devel package, versions <1:18.14.2-2.module+el8.7.0+21020+b7aeeb08
Threat Intelligence
Do your applications use this vulnerable package?
In a few clicks we can analyze your entire application and see what components are vulnerable in your application, and suggest you quick fixes.
Test your applications- Snyk ID SNYK-ORACLE8-NODEJSDEVEL-5414276
- published 5 Apr 2023
- disclosed 23 Feb 2023
Introduced: 23 Feb 2023
CVE-2023-23918 Open this link in a new tabHow to fix?
Upgrade Oracle:8
nodejs-devel
to version 1:18.14.2-2.module+el8.7.0+21020+b7aeeb08 or higher.
This issue was patched in ELSA-2023-1583
.
NVD Description
Note: Versions mentioned in the description apply only to the upstream nodejs-devel
package and not the nodejs-devel
package as distributed by Oracle
.
See How to fix?
for Oracle:8
relevant fixed versions and status.
A privilege escalation vulnerability exists in Node.js <19.6.1, <18.14.1, <16.19.1 and <14.21.3 that made it possible to bypass the experimental Permissions (https://nodejs.org/api/permissions.html) feature in Node.js and access non authorized modules by using process.mainModule.require(). This only affects users who had enabled the experimental permissions option with --experimental-policy.
References
- https://linux.oracle.com/cve/CVE-2023-23918.html
- https://linux.oracle.com/errata/ELSA-2023-1582.html
- https://linux.oracle.com/errata/ELSA-2023-1583.html
- https://linux.oracle.com/errata/ELSA-2023-1743.html
- https://linux.oracle.com/errata/ELSA-2023-2654.html
- https://linux.oracle.com/errata/ELSA-2023-2655.html
- https://nodejs.org/en/blog/vulnerability/february-2023-security-releases/
- https://security.netapp.com/advisory/ntap-20230316-0008/